Taylor, Cottrill, Erickson & Associates, Inc. Amgen Inc Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$340 Million
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $6.07 Million - $6.95 Million	-30,522 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $49,246 - $57,698	232 Added 0.77%	30,522 $6.49 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $1.03 Million - $1.14 Million	-4,391 Reduced 12.66%	30,290 $7.38 Million
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $1,553 - $1,810	7 Added 0.02%	34,681 $8.63 Million
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $123,985 - $147,644	-573 Reduced 1.63%	34,674 $7.97 Million

Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $43,175 - $48,014	-184 Reduced 0.52%	35,247 $8.96 Million
Q2 2020 Jul 14, 2020	SELL	$197.81 - $242.74 $33,232 - $40,780	-168 Reduced 0.47%	35,431 $8.36 Million
Q1 2020 Apr 15, 2020	SELL	$182.24 - $241.7 $189,165 - $250,884	-1,038 Reduced 2.83%	35,599 $7.22 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $100,470 - $129,139	-531 Reduced 1.43%	36,637 $8.83 Million
Q3 2019 Oct 25, 2019	SELL	$174.11 - $208.62 $110,733 - $132,682	-636 Reduced 1.68%	37,168 $7.19 Million
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $6,334 - $7,425	-38 Reduced 0.1%	37,804 $6.97 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $9,224 - $10,397	-51 Reduced 0.13%	37,842 $7.19 Million
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $3,211 - $3,748	-18 Reduced 0.05%	37,893 $7.38 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $161,943 - $182,569	-874 Reduced 2.25%	37,911 $7.86 Million
Q2 2018 Jul 30, 2018	BUY	$166.05 - $186.51 $36,032 - $40,472	217 Added 0.56%	38,785 $7.16 Million
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $17,620 - $20,592	-104 Reduced 0.27%	38,568 $6.58 Million
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $2,531 - $2,828	-15 Reduced 0.04%	38,672 $6.73 Million
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $6.47 Million - $7.39 Million	38,687	38,687 $7.21 Million

Others Institutions Holding AMGN

# of Institutions

2,939

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account